Trametinib inhibits RAS-mutant MLL-rearranged acute lymphoblastic leukemia at specific niche sites and reduces ERK phosphorylation in vivo

曲美替尼在特定微环境位点抑制RAS突变型MLL重排急性淋巴细胞白血病，并降低体内ERK磷酸化水平。